There are many ways of compensating, retaining or attracting employees. Among them is the use of employee stock options. Whereas they may be deemed to be favorable, numerous businesses and corporations are getting rid of them by ceasing to provide them to their employees. Some of the reasons behind the decision to scrap the use of employee stock options include additional accounting burdens, instability of options value since they are dependent on ideal economic conditions, and that employees can fail to exercise their options if the stock value falls significantly.
All the same, there are also different situations where stock options are ideal for the employees. For instance, in a scenario where the businesses or corporations share value rises incredibly, personal earning increase as well due to the higher value of the stocks. Accordingly, all the staff devotes their time and skills unreservedly to see that the corporation grows. If a firm wants to reap the benefits of stock options, it must use a perfect strategy such as the Knockout one. Although Knockout options are not guaranteed to provide an overall solution to everything, they help maneuver main obstacles linked with stock-based compensation. Jeremy Goldstein is a professional attorney who partners with corporations to help them pick the best employee benefits system through legal and acceptable ways.
Today, Jeremy Goldstein is one of the active partners at Jeremy L. Goldstein & Associates LLC. Basically, it can be described as a boutique law firm that advises management teams, CEOs, and compensation committees in executive compensation and other governance matters. Before becoming a partner of the above-mentioned law-firm, Jeremy Goldstein was an active partner in the execution of roles in Wachtell, Lipton, Rosen & Katz. He has a Bachelor’s degree in Art History, and master’s degree on the same obtained from the University of Chicago. Between 1996 and 1999, Jeremy Goldstein was a student at the New York University School of Law.
The knowledge, experience, and works of Mr. Jeremy Goldstein have made him be recognized and listed as one of the leading executive compensation attorneys in The Legal 500. Some of the significant involvement he has been involved in include the acquisition of Sanofi-Aventis by Genzyme, Goodrich by United Technologies, and the Dow Chemical Company by Rohm and Haas Company. Besides being a member of different professional advisory boards, Jeremy Goldstein has been a volunteer at Fountain House, a recovery home for people with mental illnesses, since 2008.
Follow Jeremy Goldstein on Facebook for updates.